Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats

Journal of Ethnopharmacology

Volumn 115, Issue 3, 2007, Pages 473-482

  Park, Seung Y ^a   Choi, Yoo H ^a   Lee, Wan ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Adipocytes; Dangnyohwan; GLUT4; Insulin resistance; OLETF rat

Indexed keywords

CARBON 14; DANGNYOHWAN; DEOXYGLUCOSE; GLUCOSE TRANSPORTER 4; HERBACEOUS AGENT; INSULIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE TOLERANCE TEST; GLUCOSE UTILIZATION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

RATTUS;

EID: 37549070346     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.10.040     Document Type: Article

References (51)

1. Abel E.D., Peroni O., Kim J.K., Kim Y.B., Boss O., Hadro E., Minnemann T., Shulman G.I., and Kahn B.B. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409 (2001) 729-733
2. Aledo J.C., Lavoie L., Volchuk A., Keller S.R., Klip A., and Hundal H.S. Identification and characterization of two distinct intracellular GLUT4 pools in rat skeletal muscle: evidence for an endosomal and an insulin-sensitive GLUT4 compartment. Biochemical Journal 325 (1997) 727-732
3. Baron A.D., Laakso M., Brechtel G., and Edelman S.V. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy. Journal of Clinical Investigation 87 (1991) 1186-1194
4. Berger J., Biswas C., Vicario P.P., Strout H.V., Saperstein R., and Pilch P.F. Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature 340 (1989) 70-72
5. Bryant N.J., Govers R., and James D.E. Regulated transport of the glucose transporter GLUT4. Nature reviews. Molecular Cell Biology 3 (2002) 267-277
6. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends in Biochemical Sciences 29 (2004) 18-24
7. Chen W.C., Hayakawa S., Yamamoto T., Su H.C., Liu I.M., and Cheng J.T. Mediation of beta-endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Medica 70 (2004) 113-116
8. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 (1987) 156-159
9. Cushman S.W., and Wardzala L.J. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. Journal of Biological Chemistry 255 (1980) 4758-4762
10. Dean D.J., Brozinick Jr. J.T., Cushman S.W., and Cartee G.D. Calorie restriction increases cell surface GLUT-4 in insulin-stimulated skeletal muscle. American Journal of Physiology 275 (1998) E957-E964
11. DeFronzo R.A. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35 (1992) 389-397
12. Dey L., Xie J.T., Wang A., Wu J., Maleckar S.A., and Yuan C.S. Anti-hyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine 10 (2003) 600-605
13. Duguay A., and Plaa G.L. Altered cholesterol synthesis as a mechanism involved in methyl isobutyl ketone-potentiated experimental cholestasis. Toxicology and Applied Pharmacology 147 (1997) 281-288
14. Garvey W.T., Maianu L., Hancock J.A., Golichowski A.M., and Baron A. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41 (1992) 465-475
15. Garvey W.T., Maianu L., Huecksteadt T.P., Birnbaum M.J., Molina J.M., and Ciaraldi T.P. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. Journal of Clinical Investigation 87 (1991) 1072-1081
16. Han J.C., Park S.Y., Hah B.G., Choi G.H., Kim Y.K., Kwon T.H., Kim E.K., Lachaal M., Jung C.Y., and Lee W. Cadmium induces impaired glucose tolerance in rat by down-regulating GLUT4 expression in adipocytes. Archives of Biochemistry and Biophysics 413 (2003) 213-220
17. Handberg A., Kayser L., Hoyer P.E., and Vinten J. A substantial part of GLUT-1 in crude membranes from muscle originates from perineurial sheaths. American Journal of Physiology 262 (1992) E721-E727
18. Hayashi T., Hirshman M.F., Kurth E.J., Winder W.W., and Goodyear L.J. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47 (1998) 1369-1373
19. Henry R.R., Scheaffer L., and Olefsky J.M. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism 61 (1985) 917-925
20. Hikino H., Yoshizawa M., Suzuki Y., Oshima Y., and Konno C. Isolation and hypoglycemic activity of trichosans A, B, C, D, and E: glycans of Trichosanthes kirilowii roots. Planta Med 55 (1989) 349-350
21. Hsu F.L., Liu I.M., Kuo D.H., Chen W.C., Su H.C., and Cheng J.T. Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. Journal of Natural Products 66 (2003) 788-792
22. Ishikawa M., and Koga K. Measurement of abdominal fat by magnetic resonance imaging of OLETF rats, an animal model of NIDDM. Magnetic Resonance Imaging 16 (1998) 45-53
23. Kahn B.B., Cushman S.W., and Flier J.S. Regulation of glucose transporter-specific mRNA levels in rat adipose cells with fasting and refeeding. Implications for in vivo control of glucose transporter number. Journal of Clinical Investigation 83 (1989) 199-204
24. Kahn B.B., and Flier J.S. Obesity and insulin resistance. Journal of Clinical Investigation 106 (2000) 473-481
25. Kawano K., Hirashima T., Mori S., and Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Research and Clinical Practice 24 (1994) S317-S320
26. Kraegen E.W., James D.E., Jenkins A.B., and Chisholm D.J. Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. American Journal of Physiology 248 (1985) E353-E362
27. Kurth-Kraczek E.J., Hirshman M.F., Goodyear L.J., and Winder W.W. 5′ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48 (1999) 1667-1671
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
29. Lee W., Ryu J., Souto R.P., Pilch P.F., and Jung C.Y. Separation and partial characterization of three distinct intracellular GLUT4 compartments in rat adipocytes. Subcellular fractionation without homogenization. Journal of Biological Chemistry 274 (1999) 37755-37762
30. Malide D., St-Denis J.F., Keller S.R., and Cushman S.W. Vp165 and GLUT4 share similar vesicle pools along their trafficking pathways in rat adipose cells. FEBS Letters 409 (1997) 461-468
31. Miura T., Ichiki H., Iwamoto N., Kato M., Kubo M., Sasaki H., Okada M., Ishida T., Seino Y., and Tanigawa K. Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside. Biological & Pharmaceutical Bulletin 24 (2001) 1009-1011
32. Miura T., Suzuki W., Ishihara E., Arai I., Ishida H., Seino Y., and Tanigawa K. Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes. European Journal of Endocrinology 145 (2001) 785-790
33. Mueckler M. Facilitative glucose transporters. European Journal of Biochemistry 219 (1994) 713-725
34. Pedersen O., Bak J.F., Andersen P.H., Lund S., Moller D.E., Flier J.S., and Kahn B.B. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39 (1990) 865-870
35. Rampal A.L., Jhun B.H., Kim S., Liu H., Manka M., Lachaal M., Spangler R.A., and Jung C.Y. Okadaic acid stimulates glucose transport in rat adipocytes by increasing the externalization rate constant of GLUT4 recycling. Journal of Biological Chemistry 270 (1995) 3938-3943
36. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiological Reviews 75 (1995) 473-486
37. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104 (2001) 517-529
38. Sasaki S., Higashi Y., Nakagawa K., Kimura M., Noma K., Hara K., Matsuura H., Goto C., Oshima T., and Chayama K. A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension. American Journal of Hypertension 15 (2002) 302-309
39. Sato T., Man Z.W., Toide K., and Asahi Y. Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of non-insulin-dependent diabetes mellitus. FEBS Letters 407 (1997) 329-332
40. Shapiro K., and Gong W.C. Natural products used for diabetes. Journal of the American Pharmaceutical Association (Washington) 42 (2002) 217-226
41. Shepherd P.R., Gnudi L., Tozzo E., Yang H., Leach F., and Kahn B.B. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. Journal of Biological Chemistry 268 (1993) 22243-22246
42. Shepherd P.R., and Kahn B.B. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. New England Journal of Medicine 341 (1999) 248-257
43. Smith U. Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance-is insulin resistance initiated in the adipose tissue?. International Journal of Obesity and Related Metabolic Disorders 26 (2002) 897-904
44. Standaert M.L., Bandyopadhyay G., Perez L., Price D., Galloway L., Poklepovic A., Sajan M.P., Cenni V., Sirri A., Moscat J., Toker A., and Farese R.V. Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. Journal of Biological Chemistry 274 (1999) 25308-25316
45. Toide K., Man Z.W., Asahi Y., Sato T., Nakayama N., Noma Y., Oka Y., and Shima K. Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain. Diabetes Research and Clinical Practice 38 (1997) 151-160
46. Tozzo E., Gnudi L., and Kahn B.B. Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology 138 (1997) 1604-1611
47. Watson R.T., and Pessin J.E. Intracellular organization of insulin signaling and GLUT4 translocation. Recent Progress in Hormone Research 56 (2001) 175-193
48. Wing R.R., Blair E.H., Bononi P., Marcus M.D., Watanabe R., and Bergman R.N. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 17 (1994) 30-36
49. Xu H.Q., and Hao H.P. Effects of iridoid total glycoside from Cornus officinalis on prevention of glomerular overexpression of transforming growth factor beta 1 and matrixes in an experimental diabetes model. Biological & Pharmaceutical Bulletin 27 (2004) 1014-1018
50. Yasuda N., Nagakura T., Yamazaki K., Inoue T., and Tanaka I. Improvement of high fat-diet-induced insulin resistance in dipeptidyl peptidase IV-deficient Fischer rats. Life Sciences 71 (2002) 227-238
51. Yoon M.J., Lee G.Y., Chung J.J., Ahn Y.H., Hong S.H., and Kim J.B. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55 (2006) 2562-2570